A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata, Alopecia Universalis or Alopecia Totalis
StatusActive
Effective start/end date6/15/186/30/22

Funding

  • ACLARIS THERAPEUTICS, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.